Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SkinBioTherapeutics ( (GB:SBTX) ) has issued an update.
SkinBioTherapeutics plc announced that its trading has begun positively for the new financial year, reaffirming that its 2026 full-year revenue and adjusted EBITDA projections remain on target at £6.2 million and £0.7 million, respectively. This positive outlook reflects the company’s ongoing efforts to solidify its market position in the skincare and gut-skin health sectors, which is bolstered by its partnerships, innovative product lines, and strategic expansion initiatives.
The most recent analyst rating on (GB:SBTX) stock is a Sell with a £16.00 price target. To see the full list of analyst forecasts on SkinBioTherapeutics stock, see the GB:SBTX Stock Forecast page.
Spark’s Take on GB:SBTX Stock
According to Spark, TipRanks’ AI Analyst, GB:SBTX is a Underperform.
SkinBioTherapeutics faces significant financial challenges with ongoing losses and cash burn, which heavily influence its stock score. While technical indicators show bearish trends, recent positive corporate events and strategic moves offer potential future benefits. However, until these translate into improved financial performance, the stock’s score remains low.
To see Spark’s full report on GB:SBTX stock, click here.
More about SkinBioTherapeutics
SkinBioTherapeutics is a UK-based life science company focused on skin health, leveraging its proprietary SkinBiotix® platform technology developed by the University of Manchester. Its primary business areas include cosmetic skincare and food supplements targeting the gut-skin axis, marketed under AxisBiotix™, with products available via partnerships, retail outlets like Superdrug, and Amazon. The company also pursues strategic acquisitions to expand its distribution, geographical reach, and manufacturing capabilities.
Average Trading Volume: 1,115,437
Technical Sentiment Signal: Sell
Current Market Cap: £35.26M
See more insights into SBTX stock on TipRanks’ Stock Analysis page.